CTC 15% w/w Oral Powder

Country: Irlanda

Lingwa: Ingliż

Sors: HPRA (Health Products Regulatory Authority)

Ingredjent attiv:

Chlortetracycline hydrochloride

Disponibbli minn:

Univet Limited

Kodiċi ATC:

QJ01AA03

INN (Isem Internazzjonali):

Chlortetracycline hydrochloride

Dożaġġ:

15 percent weight/weight

Għamla farmaċewtika:

Oral powder

Tip ta 'preskrizzjoni:

POM: Prescription Only Medicine as defined in relevant national legislation

Grupp terapewtiku:

Cattle, Pigs

Żona terapewtika:

chlortetracycline

Indikazzjonijiet terapewtiċi:

Antibacterial

L-istatus ta 'awtorizzazzjoni:

Authorised

Data ta 'l-awtorizzazzjoni:

1999-02-19

Karatteristiċi tal-prodott

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CTC 15% w/w Oral Powder.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains
ACTIVE SUBSTANCE
Chlortetracycline hydrochloride
150 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral Powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves (less than 6 months of age) and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves:
The product is indicated as an aid in the treatment of respiratory
disease in calves caused by_ Pasteurella spp_., sensitive
to chlortetracycline.
Pigs:
The product is indicated as an aid in the treatment of respiratory
disease in pigs caused by micro-organisms sensitive to
chlortetracycline.
4.3 CONTRAINDICATIONS
Do not use in adult ruminants, dairy cows and veal calves.
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_8_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_9_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Ideally, use of the product should be based on susceptibility testing.
Inappropriate use of the product may increase the prevalence of
bacteria resistant to chlortetracycline and may decrease
the effectiveness of treatment with related substances, due to the
potential for cross-resistance.
To e